Topics:
Tuesday, January 15, 2013, 8:30am-10:25am EST
Hyatt Regency, Pier 66, Ft. Lauderdale, FL
Session Co-Chairs:
- Joel L. Kaar, University of Colorado, Boulder
- Hadley D. Sikes, Massachusetts Institute of Technology
Invited Speakers:
- Matt DeLisa, Cornell University- Bottom-up bacterial glycoengineering: from enzymes and pathways to human therapies and vaccines
Oral Presentations:
- Rudi Fasan, University of Rochester: Fingerprint-Guided Engineering of Selective P450 Catalysts for C—H Functionalization in Complex Molecules
- Peter Tessier, Rensselaer Polytechnic Institute: Antibodies by Design
- Marc Ostermeier, Johns Hopkins University: A Protein Therapeutic Modality Founded On Molecular Regulation
- Kurt Deshayes, Genentech: Altering the Apoptotic Network in Cancer: A Promising Therapeutic Approach
